Schedule 13G ownership disclosure

Mirum Pharmaceuticals Inc

Security class unavailable · CUSIP: 604749101

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,859,151
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001395064-21-000006
Form type
SC 13G/A
Filer
Mirum Pharmaceuticals, Inc.
CIK
CIK 1759425
Filed
Jan 27, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub